A 3-year study of tirzepatide in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 trial results: https://t.co/5TTgJfbKyo
Awesome trial...the power of combo anithypertensives!
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment … https://t.co/NyYEo73KCC
Simple, scalable, and cost-efficient electronic letter strategies, used in this study to encourage flu vaccinations, may have substantial public health implications.
https://t.co/qKN1Le4v5F
Happy to share this article led by @harvardmed student (now IM intern), Dr. Lynn-Green! We explore time efficient versions of the SPRINT protocol!
Clinical Impact of 3- vs 5-Minute Delay & 30- versus 60-Second Intervals on Unattended Automated Office BP
https://t.co/x2mVbxC71i
New blog article challenging medical researchers who are drawn to clustering patients to create so-called "phenotypes" to think again: https://t.co/50fqPRSLLl @MaartenvSmeden@statsepi0#Statistics#PrecisionMedicine @vandy_biostat
Three years ago, I set out to create a DAG for my research but found limited guidance. This led to a scoping review, including an illustrative case from health psychology. I hope it helps researchers explore and use DAGs in their work!
I'm excited to share the next version of patchwork with the world, available on CRAN now. First class support for gt tables and even more freedom with `free()`
https://t.co/wDzUHGbCRl
New manuscript "Addressing the credibility crisis in Mendelian randomization" is out at @BMCMedicine: https://t.co/TzaAvFrPxL. We discuss the explosion in MR studies, and what can be done by authors and editors/reviewers to improve the quality of published MR research. Thread:
New #bloodpressure measurement devices such as cuff-less wrist monitors are likely to play an important role in future – but several challenges remain before these new technologies can be introduced widely - new @ISHBP position paper out today.
Read more: https://t.co/VGmnZoJvo4
'Depicting deterministic variables within directed acyclic graphs (DAGs): An aid for identifying & interpreting causal effects involving derived variables and compositional data'
Thrilled this has been published in @AmJEpi! Pls share!
#EpiTwitter 1/10
https://t.co/liP0ewnjVH
🧵 New Special Communication examines drawing causal inferences about the effects of interventions from observational studies in medical journals and suggests a framework that might be used.
https://t.co/2KoFti2nQl
The @US_FDA proposal to allow use of salt substitutes (aka Potassium salt) for processed food
https://t.co/SoYVNbMVPl
Until now, FDA has *prohibited* using salt substitute
1/
Helpful review of potassium-enriched salt substitutes for #hypertension. But how to find them? I found some online with 50% or more potassium, but those can taste bitter. Has anyone been able to find 25% potassium salt in the US market?
https://t.co/cgC6u7MOLW
Congratulations to Gotham Health, Morrisania for being recognized by Million Hearts as a 2023 Hypertension Control Champion, the only clinic in New York State to receive this prestigious award in 2023. Read more: https://t.co/FHOGFASywK
We're hiring! My team has a new position focused on our initiatives around prevention and management of cardiometabolic conditions, particularly #hypertension, #diabetes, and #hyperlipidemia. Perfect for a recent MPH grad or similar background. https://t.co/dj3Wkyb2Bb
Vegan vs Omnivore diet - in IDENTICAL TWINS
Our study is out today!
Huge shout out to entire study team!
Especially co-first authors @TheGuyititian & @catepward
OMG...twins are so much fun to work with!
Stay tuned for Netflix docuseries! Jan2024
https://t.co/GJ0BThFpFO
What an honor! 18 of our sites were recognized by @American_Heart for our work in helping patients manage their diabetes. 17 sites received Gold status, the highest recognition, for having fewer than 25% of patients with poorly controlled diabetes: https://t.co/0tAArgdd9V.